Healthcare provider profile · identity verified

Subashini Anand, M.D.

Family Practice · JACKSONVILLE, FL · NPI 1043370752

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	352	115
Atorvastatin Calcium	Atorvastatin Calcium	307	92
Amlodipine Besylate	Amlodipine Besylate	227	76
Gabapentin	Gabapentin	221	62
Levothyroxine Sodium	Levothyroxine Sodium	218	65
Fluticasone Propionate	Fluticasone Propionate	198	86
Omeprazole	Omeprazole	196	65
Lisinopril	Lisinopril	180	55
Jardiance	Empagliflozin	137	29
Metformin Hcl	Metformin Hcl	135	39
Losartan Potassium	Losartan Potassium	133	44
Ozempic	Semaglutide	132	27
Alprazolam	Alprazolam	105	18
Hydrochlorothiazide	Hydrochlorothiazide	103	32
Trazodone Hcl	Trazodone Hcl	101	35
Escitalopram Oxalate	Escitalopram Oxalate	96	31
Metoprolol Succinate	Metoprolol Succinate	91	31
Albuterol Sulfate Hfa	Albuterol Sulfate	86	38
Pantoprazole Sodium	Pantoprazole Sodium	83	31
Montelukast Sodium	Montelukast Sodium	79	29
Metoprolol Tartrate	Metoprolol Tartrate	73	24
Tamsulosin Hcl	Tamsulosin Hcl	68	29
Furosemide	Furosemide	67	20
Sertraline Hcl	Sertraline Hcl	67	19
Famotidine	Famotidine	64	21
Eliquis	Apixaban	62	15
Alendronate Sodium	Alendronate Sodium	60	26
Simvastatin	Simvastatin	57	19
Spironolactone	Spironolactone	57	15
Amoxicillin	Amoxicillin	55	40
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	55	20
Zolpidem Tartrate	Zolpidem Tartrate	49	suppressed
Clopidogrel	Clopidogrel Bisulfate	48	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	suppressed
Duloxetine Hcl	Duloxetine Hcl	45	16
Meloxicam	Meloxicam	45	14
Tizanidine Hcl	Tizanidine Hcl	43	suppressed
Tramadol Hcl	Tramadol Hcl	43	16
Clonazepam	Clonazepam	42	suppressed
Pravastatin Sodium	Pravastatin Sodium	41	13
Allopurinol	Allopurinol	40	13
Mirtazapine	Mirtazapine	40	11
Carvedilol	Carvedilol	38	13
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	38	11
Synthroid	Levothyroxine Sodium	37	suppressed
Prednisone	Prednisone	36	30
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	36	suppressed
Valacyclovir	Valacyclovir Hcl	36	suppressed
Diclofenac Sodium	Diclofenac Sodium	35	13
Buspirone Hcl	Buspirone Hcl	33	12
Shingrix	Varicella-Zoster Ge/As01b/Pf	33	27
Pregabalin	Pregabalin	32	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	11
Ketoconazole	Ketoconazole	29	12
Naproxen	Naproxen	27	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	27	suppressed
Bupropion Hcl Sr	Bupropion Hcl	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Azithromycin	Azithromycin	25	23
Methylprednisolone	Methylprednisolone	25	23
Potassium Chloride	Potassium Chloride	25	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	13
Azelastine Hcl	Azelastine Hcl	23	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Nystatin	Nystatin	22	12
Propranolol Hcl	Propranolol Hcl	22	suppressed
Rybelsus	Semaglutide	22	suppressed
Finasteride	Finasteride	21	suppressed
Fluconazole	Fluconazole	21	13
Tresiba Flextouch U-100	Insulin Degludec	21	suppressed
Atenolol	Atenolol	20	suppressed
Baclofen	Baclofen	20	11
Doxycycline Hyclate	Doxycycline Hyclate	20	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Estradiol	Estradiol	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	13
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	16	suppressed
Lactulose	Lactulose	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	14	14
Ibuprofen	Ibuprofen	14	suppressed
Megestrol Acetate	Megestrol Acetate	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	13	13
Glimepiride	Glimepiride	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Topiramate	Topiramate	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Hydrocortisone	Hydrocortisone	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	12
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error